News

A high fasting insulin level trajectory was associated with psychosis, while puberty-onset BMI increase was linked to depression.

A new study has identified various potential clinical predictors associated with poor outcomes, including mortality, in patients with sickle cell disease.

The researchers unexpectedly found sustained visual improvement in both eyes, despite only 1 eye being treated with AAV.

A phase 2 study suggests treating the common diabetes comorbidity may be capable with the monoclonal antibody.

CTx-1301's formulation enables 3 different doses within 1 pill for ADHD.

The randomized, blinded trial evaluated the safety and reactogenicity of aIIV3 and HD-IIV3 in adults 65 and older.

Researchers are prepared a phase 3 trial testing the treatment in adults with ADHD.

The role of many in psychiatry has changed during the COVID-19 pandemic.

Such scores could provide insight into the significant comorbidity rate of ADHD and other youth mood and emotional dysregulation issues.

Randomized controlled trials are needed to evaluate their efficacy in comparison with in-person group meetings.

Investigators have observed a development-related shift in risks from teenaged ADHD and alcohol use risks in the patients' 30s.

A pair of researchers present plans to improve collaboration with other professionals in ADHD.

The likelihood of smoking addiction is associated with traits also closely associated with worsened ADHD.

An ADHD coach can work on more goal-based plans for individuals with ADHD.

A study finds that secondhand smoking may have a greater negative impact on children than prenatal smoke exposure.

There is a high association between parents' concerns of autism spectrum disorder in their children and identified symptoms of ADHD.

There is currently no approved treatment for fragile X syndrome.

Current estimates indicate that non-adherence to stimulants is as high as 87%.

New research expands on the understood link between sleep and ADHD-related behavior, and gives clinicians new therapeutic targets.

Though the correlation is concerning for at-risk groups, experts believe it could inform individualized psychiatric care during crises.

The APSARD study finds that most neuropsychological assessment scores did not differ significantly between both in-person and virtual visit modalities.

Methylphenidate has shown promising boosting morning function in pediatric patients with ADHD.

Both monotherapy and combination of the unique regimen was shown to improve manic and depressive status at 12 weeks.

The Child Behavior Checklist may provide invaluable information to clinicians regarding the type and severity of comorbid psychopathologies.

The treatment improves morning function for adolescent ADHD patients.

The indication is the first of its kind for the rare, sometimes quickly fatal disease.

Dr. David Goodman predicts some patients may improve their organizational skills during the pandemic.

Adults with ADHD may face a number of challenges during the ongoing pandemic.